-- Innovent Biologics (HKG:1801) recorded a 50% year over year growth in total product revenue during the first quarter of 2026, according to a Hong Kong bourse filing Thursday.
The firm generated 3.8 billion yuan in total product revenue during the period on the back of its oncology pipeline and general biomedicine franchise.
Piccadilly Agro Industries' (NSE:PICCADIL,BOM:530305) consolidated net profit rose to 452.3 million Indian rupees in the fiscal fourth quarter ended March 31, from 398.0 million rupees a year ago.Earnings per share came in at 4.62 rupees from 4.22 rupees a year earlier, the alcoholic beverages manufacturer said in a filing to the Indian stock exchanges on Tuesday.Revenue from operations in fiscal Q4 also increased to 3.60 billion rupees from 2.72 billion rupees a year ago.
Shenzhen Hepalink Pharmaceutical (HKG:9989, SHE:002399) posted net profit attributable to shareholders of 187.6 million yuan for the first quarter, up 20% from 156.6 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the pharmaceutical firm were up over 1% in Thursday's late morning trade.Earnings per share came in at 0.1278 yuan, compared with 0.1067 yuan a year earlier.Operating revenue fell 4.6% to 1.33 billion yuan from 1.39 billion yuan in the prior-year period.
Stoneweg Europe Stapled Trust (SGX:SET) completed the divestment of a Polish office asset named Riverside Park for 22.5 million euros, according to a Thursday filing with the Singapore Exchange.The divestment is part of the trust's strategy to recycle capital, with proceeds to be used to invest in logistics and data centers.